The 5-HT2 antagonist ritanserin blocks dopamine re-uptake in the rat frontal cortex

Molecular Psychiatry

Volumn 5, Issue 6, 2000, Pages 673-677

  Ruiu, S ^a   Marchese, G ^a   Saba, P L ^b   Gessa, G L ^a,b,c   Pani, L ^a,b,c  

^a Neuroscienze PharmaNess Scarl   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c CNR   (Italy)

Author keywords

Antipsychotics; Cocaine; DAT; Neuroleptics; Synaptosomes

Indexed keywords

COCAINE; DOPAMINE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE TRANSPORTER; HALOPERIDOL; NEUROLEPTIC AGENT; RACLOPRIDE; RISPERIDONE; RITANSERIN; SEROTONIN 2 ANTAGONIST; CLOZAPINE; DIAGNOSTIC AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE UPTAKE INHIBITOR; KETANSERIN; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; COGNITION; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG POTENCY; DRUG RECEPTOR BINDING; FRONTAL CORTEX; MALE; MOOD; NONHUMAN; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; ANIMAL; FRONTAL LOBE; METABOLISM; SPRAGUE DAWLEY RAT; SYNAPTOSOME;

ANIMALS; CLOZAPINE; COCAINE; DOPAMINE; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; FRONTAL LOBE; HALOPERIDOL; KETANSERIN; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; RISPERIDONE; RITANSERIN; SEROTONIN ANTAGONISTS; SYNAPTOSOMES; TRITIUM;

EID: 0033623657     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000804     Document Type: Article

References (31)

1. Typical and atypical neuroleptics: Differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons
2. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: An in vivo microdialysis study
3. Receptor interactions of new antipsychotics: Relation to pharmacodynamic and clinical effects
4. Serotonergic component of neuroleptic receptors
5. 2 pKi values
6. 2 antagonist
7. 2 receptor blocking agent
8. Thymostenic agents, a novel approach in the treatment of schizophrenia
9. 2 antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition
10. 2 receptor antagonist, ritanserin
11. Local infusion of the serotonin antagonists ritanserin or ICS 205,930 increases in vivo dopamine release in the rat prefrontal cortex
12. Neurochemical effects of chronic co-administration of ritanserin and haloperidol: Comparison with clozapine effects
13. 2 dopamine receptor blockade
14. 2 antagonists on haloperidol-induced dyskinesias in squirrel monkeys: No evidence for reciprocal 5-HT-dopamine interaction
15. Ritanserin facilitates anxiety in a simulated public-speaking paradigm
16. Ritanserin in the treatment of cocaine dependence
17. Pharmacological profile of neuroleptics at human monoamine transporters
18. Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: Most antidepressants selectively block norepinefrine uptake
19. Cloning and expression of a cocaine-sensitive dopamine transporter cDNA
20. Neurotransmitter transporters: Recent progress
21. Amphetamine and other weak basis act to promote reverse transport of dopamine in ventral midbrain neurons
22. Ritanserin administration potentiates amphetamine-stimulated dopamine release in the rat prefrontal cortex
23. Role and localization of serotonin2 (S2)-receptor-binding sites: Effects of neuronal lesions
24. 2 receptors throughout the rat central nervous system using quantitative antoradiography
25. 2 and 5-Hydroxytryptamine(1A) receptors mediate opposing responses on membrane excitability in rat association cortex
26. 2 receptors in the rat brain
27. Risperidone: Regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain
28. Effects of amperozide, a putative antipsychotic drug, on rat midbrain dopamine neurons recorded in vivo
29. Implications of normal brain development for the pathogenesis of schizophrenia
30. Biochemical profile of risperidone a new antipsychotic
31. Dopamine uptake by rat striatal synaptosomes: Time and temperature-dependent decay and protection by dithiothreitol and dopamine